( GAITHERSBURG Md. May 2 /PRNewswire-Fi...)Pediatric Academic Societies' Annual Meeting to Feature Data,Presentations Related to MedImmune Clinical Programs in Influenza,,RSV and hMPV,Health

GAITHERSBURG, Md., May 2 /PRNewswire-FirstCall/ -- MedImmune, Inc. (Nasdaq: MEDI) today announced that seven abstracts will be presented at the 2007 Pediatric Academic Societies' (PAS) Annual Meeting demonstrating the company's commitment to advancing the science of pediatric medicine. Data are from studies pertaining to MedImmune's approved and development-stage products, including both monoclonal antibodies and vaccines targeting respiratory infectious diseases such as influenza, respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).

"MedImmune is dedicated to advancing research on the prevention and treatment of infectious diseases that put children at risk," said Edward M. Connor, M.D., executive vice president and chief medical officer. "We are committed to improving children's health both with our currently marketed products and through the potential of our robust infectious disease pipeline."

During the PAS meeting, which occurs from May 5 to 8, 2007 in Toronto, Canada, MedImmune will award several pediatric research grants through the company's annual pediatric fellowship program, which is designed to stimulate increased interest and research in the area of respiratory pathogens. Over the last 3 years, MedImmune has awarded pediatric research grants totaling nearly $700,000. In addition, MedImmune currently supports two other research grants through the Pediatric Infectious Disease Society, which will also be awarded in conjunction with the PAS annual meeting.

Data pertaining to MedImmune infectious disease programs that will be presented during the meeting include:

    Influenza
    -- School-Based Influenza Vaccination of Elementary Students Reduced
       Countywide School Absenteeism (Platform Presentation) -- M. Davis et
       al, Saturday, May 5, 2007 from 4:45 p.m.-5:00 p.m. Eastern Time (ET),
       Metro Toronto Convention Centre, Room 206F
    -- Economic 
'"/>




Page: 1 2 3 4 
Related medicine technology :

1. Generex Biotechnology to Make Presentations At 46th Annual Meeting
of the European Society of Pediatric Endocrinology
2. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab)
May Reduce Subsequent Recurrent Wheezing in Preterm Infants
3. Neuroblastoma Expert Reviews Progress and Challenges in Fighting
Difficult Pediatric Cancer
4. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators
Published in Pediatrics
5. New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At
Annual Digestive Disease Week Meeting
6. Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric
Academic Societies Annual Meeting
7. Research Results on FluMist Presented at National Association of
Pediatric Nurse Practitioners Conference
8. Replidyne Phase II Pediatric Trial Meets Primary Objective
9. Inspiration Biopharmaceuticals Presents Data From Hemophilia
Program at International Society On Thrombosis and Haemostasis
(ISTH) Annual Meeting
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule
Therapeutic Clinical Trial Results Presented at the 34th Annual
Meeting of the Controlled Release Society
11. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin
Emerging Growth Conference